European Archives - Page 5 of 1042 - European Medical Journal

Broccoli Compound Linked to Improved Blood Sugar Levels in Prediabetes

Researchers have found that sulforaphane, a chemical compound found in broccoli sprouts, can significantly improve blood sugar levels in people with prediabetes.

Enhancing Immunotherapy by Targeting Specific Receptors in Ovarian Cancer

These findings highlight a host-intrinsic mechanism responsible for the failure of PD-L1 blockade in ovarian cancer.

Improving Clinic Capacity with Faricimab

In many countries globally, ophthalmology clinics are over capacity, resulting in treatment delays and a reduction in the quality of…

IMCAS World Congress 2025

The IMCAS World Congress convened over 20,000 attendees from 140 countries, including a diverse mix of leading medical professionals, researchers, and industry representatives.

New Approach Expands Surgical Options for Patients with Liver Cancer and Cirrhosis

Immunotherapy, targeted radiation, and a refined surgical technique allowed tumour removal in a liver cancer patient previously ineligible for surgery.

Handshake on a green background

AstraZeneca pays $160m for FibroGen's China subsidary

FibroGen, Inc. has announced the sale of its Chinese subsidiary to AstraZeneca, including the rights to roxadustat in China.

Tirzepatide Lowers Left Ventricular Mass and Fat in Obesity-Related HFpEF

Tirzepatide reduces LV mass and paracardiac fat in obesity-related HFpEF, offering structural heart benefits beyond weight loss.

Wearable Device Reduces Fatigue and Raynaud Symptoms in Systemic Sclerosis

A wearable device reduced fatigue and Raynaud symptoms in systemic sclerosis, improving quality of life without adverse effects.

Predicting Methotrexate Failure in Ectopic Pregnancy

A new retrospective study has identified key risk factors for methotrexate (MTX) treatment failure in tubal ectopic pregnancy (TEP). The findings suggest that higher gravidity and elevated β-hCG levels increase the likelihood of treatment failure, while additional MTX doses improve success rates.

Scientists Identify Genetic Variants That Drive Cancer Risk and Growth

Researchers uncover genetic variants that drive cancer risk, revealing new therapeutic targets and refining genetic screening strategies.